Athenex, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- 280
- Market Cap
- -
- Website
- http://www.athenex.com
Clinical Trials
27
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (27 trials with phase data)• Click on a phase to view related trials
Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies
- Conditions
- B-cell LeukemiaDLBCL - Diffuse Large B Cell LymphomaALL, ChildhoodNHL, Relapsed, AdultB-cell LymphomaALL, Adult B CellCLL/SLL
- First Posted Date
- 2022-08-04
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Athenex, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05487651
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸OHSU - Knight Cancer Center, Portland, Oregon, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
A PK Study of Oraxol in Breast Cancer Patients
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2021-08-06
- Lead Sponsor
- Athenex, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04993040
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors
- Conditions
- Advanced Solid Tumor
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2022-09-02
- Lead Sponsor
- Athenex, Inc.
- Registration Number
- NCT04878484
A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Athenex, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT04180384
- Locations
- 🇦🇺
Monash Medical Centre, Clayton, Australia
🇳🇿Auckland City Hospital, Auckland, New Zealand
🇳🇿Dunedin Hospital, Dunedin, New Zealand
An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Athenex, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT04168957
- Locations
- 🇨🇳
Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan
🇨🇳China Medical University Hospital, Taichung city, Taiwan
🇨🇳Taipei Veterans Generla Hospital, Taipei, Taiwan, 11217, Taiwan
- Prev
- 1
- 2
- 3
- 4
- 5
- Next